Related Experiment Video
Updated: May 11, 2025
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
19.6K
Lung Microbiome in Autoimmune-Associated Interstitial Lung Disease
1Division of Rheumatology, Thomas Jefferson University, 211 South 9th Street, Suite 210, Philadelphia, PA 19107, USA.
Rheumatic Diseases Clinics of North America
|April 17, 2025
Summary
The lung microbiome influences chronic lung diseases like interstitial lung diseases (ILD). This review focuses on the lung microbiome's role in autoimmune-related ILD pathogenesis.
Area of Science:
- Pulmonary Medicine
- Microbiology
- Immunology
Background:
- The lung microbiome, a complex microbial community, plays a role in respiratory health and disease.
- Interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF), are linked to alterations in the lung microbiome.
- ILD is a known complication of various autoimmune conditions.
Purpose of the Study:
- To review recent research on the lung microbiome's involvement in the development of autoimmune-related ILD.
- To highlight the connection between microbial dysbiosis and autoimmune processes in the lungs.
Main Methods:
- Literature review of recent studies.
- Analysis of research on lung microbiota composition and function.
- Examination of the interplay between the immune system and lung microbes in autoimmune ILD.
Main Results:
- Emerging evidence suggests specific microbial profiles are associated with autoimmune ILD.
- The lung microbiome may influence immune responses, contributing to ILD pathogenesis.
- Dysbiosis can exacerbate inflammation and fibrosis in autoimmune lung conditions.
Conclusions:
- The lung microbiome is a critical factor in understanding and potentially treating autoimmune-related ILD.
- Targeting the lung microbiome may offer novel therapeutic strategies for these debilitating diseases.
